Phase 2 Evaluation of Topotecan Administered on a 3-Day Schedule in the Treatment of Platinum- and Paclitaxel-Refractory Ovarian Cancer

Author: Markman M.   Kennedy A.   Webster K.   Kulp B.   Peterson G.   Belinson J.  

Publisher: Elsevier

ISSN: 0090-8258

Source: Gynecologic Oncology, Vol.79, Iss.1, 2000-10, pp. : 116-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content